<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-934
Date of Submission: 2025-02-20

This report was submitted by a Other Healthcare Professional from Conley, Rodriguez and Harris Medical Center concerning patient ANON-PX-5394. The subject is an adult other with a significant medical history including hypertension, anxiety, asthma, osteoarthritis. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Gabapentin administered via the Intravenous route at a dosage of 155mg, initiated on 2024-11-25 for Neuropathic pain and discontinued on 2025-02-19; Warfarin (Anticoagulant) administered via the Intravenous route at a dosage of 313mg, initiated on 2024-11-25 for Thromboembolism prevention and discontinued on 2025-02-19.

On approximately 2025-02-03, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Angioedema, Vomiting, Headache. The Angioedema was classified as Moderate in severity. This necessitated clinical intervention. The documented action was: Prescribed hundred and advised western. The current patient status regarding this symptom is 'Recovered'. The Vomiting was classified as Life-threatening in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Unknown'. The Headache was classified as Life-threatening in severity. This necessitated clinical intervention. The documented action was: Prescribed economy and advised between. The current patient status regarding this symptom is 'Unknown'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 4 was calculated, The assessment concluded the relationship was 'Possible'. Dechallenge/Rechallenge status was noted as: 'Positive dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

</data>
report_id: ADR-2025-934
report_date: '2025-02-20'
patient_details:
  patient_id: ANON-PX-5394
  gender: Other
  relevant_history:
  - hypertension
  - anxiety
  - asthma
  - osteoarthritis
suspected_drugs:
- drug_name: Gabapentin
  dosage: 155mg
  route_of_administration: Intravenous
  start_date: '2024-11-25'
  indication_for_use: Neuropathic pain
  end_date: '2025-02-19'
- drug_name: Warfarin
  dosage: 313mg
  route_of_administration: Intravenous
  start_date: '2024-11-25'
  indication_for_use: Thromboembolism prevention
  drug_class: Anticoagulant
  end_date: '2025-02-19'
adverse_reactions:
- symptom_name: Angioedema
  onset_date: '2025-02-03'
  severity: Moderate
  outcome: Recovered
  intervention_required: true
  intervention_details: Prescribed hundred and advised western.
- symptom_name: Vomiting
  onset_date: '2025-02-03'
  severity: Life-threatening
  outcome: Unknown
  intervention_required: true
- symptom_name: Headache
  onset_date: '2025-02-03'
  severity: Life-threatening
  outcome: Unknown
  intervention_required: true
  intervention_details: Prescribed economy and advised between.
causality_assessment:
  assessment_conclusion: Possible
  dechallenge_rechallenge: Positive dechallenge
  naranjo_score: 4
reporting_facility: Conley, Rodriguez and Harris Medical Center
reporter_type: Other Healthcare Professional
